Why is Eiko Lifescience falling/rising?

As of 06-October, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at 51.09, which reflects a decrease of 0.8 or 1.54%. The stock has been underperforming, having lost 4.06% over the last three days and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has shown negative returns over various periods, including a year-to-date decline of 18.57% and a one-year drop of 16.53%. While there has been a rise in investor participation, with a 43.2% increase in delivery volume, the overall performance remains weak, and there are no positive or negative factors available to further explain the stock's recent movement.
In the broader market context, Eiko Lifesciences' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 1.77% over the past week while Eiko has declined by 1.84%. This underperformance is indicative of a broader trend, as the stock has consistently lagged behind the benchmark across various time frames, including a three-year return of -11.84% compared to the Sensex's impressive 40.48% gain. The liquidity of the stock remains adequate for trading, but the persistent decline in price suggests a lack of investor confidence in the company's outlook relative to the overall market.